COVID-19 intranasal vaccine iNCOVACC to be out January 26

• Bharat Biotech will launch its intranasal COVID-19 vaccine, iNCOVACC, on January 26
• It announced that it would sell the intranasal vaccine for ₹ 325 per shot for procurement by the government
• For private vaccination centers, the cost per shot will be ₹800

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine, iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said.

Interacting with students at the India International Science Festival in Bhopal, Ella also said that the homegrown vaccine for the lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month.

"Our nasal vaccine will be officially launched on January 26, on Republic Day," Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organized at the Maulana Azad National Institute of Technology (MANIT).

In December, Bharat Biotech announced that it would sell the intranasal vaccine for ₹325 per shot for procurement by the government and ₹800 per shot for private vaccination centers.